L-Alpha-Methyl-Dopa Versus the Racemic Form-a Comparative Study of the Hypotensive Effect
- 24 April 2009
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 179 (6) , 747-753
- https://doi.org/10.1111/j.0954-6820.1966.tb05499.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Alpha-Methyldopa in Arterial HypertensionActa Medica Scandinavica, 2009
- The Place of Methyldopa in the Treatment of Severe HypertensionPublished by American Medical Association (AMA) ,1963
- Methyldopa in the Treatment of HypertensionBMJ, 1963
- ALPHA-METHYLDOPA IN ARTERIAL HYPERTENSION - CLINICAL, RENAL AND HEMODYNAMIC STUDIES1963
- METHYLDOPA IN HYPERTENSION CLINICAL AND PHARMACOLOGICAL STUDIESThe Lancet, 1962
- Effect of Alpha-Methyl DOPA in Severe and Malignant HypertensionPublished by American Medical Association (AMA) ,1962
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962
- Decarboxylase inhibitors in the treatment of hypertension∗The American Journal of Cardiology, 1962
- Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopaThe American Journal of Cardiology, 1962
- Relationships Between Alterations in Amine Metabolism and Blood PressureCirculation Research, 1961